3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
2
Status
Terminated
1
Completed
1
Sponsor Class
NIH
6
OTHER
3
NETWORK
2
Study Type
Interventional
2
Sponsor
Cancer Type
Breast
2
Conditions
Neoplasms
1
Neoplasm Metastasis
1
HER2 Positive Breast Cancer
1
Breast Neoplasms
1
Interventions
Cyclophosphamide
42
Docetaxel
33
Paclitaxel
31
Tamoxifen
29
Doxorubicin
29
Trastuzumab
25
Radiotherapy
21
Epirubicin
16
Letrozole
15
Anastrozole
12
exemestane
11
Fluorouracil
11
Capecitabine
10
Bevacizumab
10
palbociclib
9
Immunohistochemistry
9
Fulvestrant
9
Filgrastim
9
Lapatinib
8
Zoledronic Acid
7
Methotrexate
7
Magnetic Resonance Spectroscopy
7
Gene Expression Profiling
7
pertuzumab
6
Triptorelin Pamoate
6
Taxes
6
Surgical Procedures, Operative
6
Microarray Analysis
6
Goserelin
6
Chemotherapy, Adjuvant
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
NETWORK
×
copanlisib
×
Breast
×
Clear all
NCT02705859
2026-04-13
Panther
Cancer Trials Ireland
Phase 1
Completed
26 enrolled
NCT04042051
2025-07-22
Panthera
Cancer Trials Ireland
Phase 1
Terminated
2 enrolled